MarketCap
Danaher Corporation DHR
€ 178.57
0.53%
Facebook
X
Telegram
Danaher Corporation EV | DHR
EV Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 B | 150 B | 177 B | 175 B | 193 B | 148 B | 133 B | 95.2 B | 90.3 B | 76.8 B | 69.5 B | 54.4 B | 48.8 B | 43.7 B | 39.3 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 193 B | 39.3 B | 109 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Centogene N.V.
CNTG
|
-8.4 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 288.5 | 0.54 % | $ 14.3 B | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
DarioHealth Corp.
DRIO
|
11 M | $ 7.24 | 3.72 % | $ 28.8 M |  Israel |
 |
Brainsway Ltd.
BWAY
|
231 M | $ 14.15 | 1.61 % | $ 481 M | Israel |
 |
Celcuity
CELC
|
5.57 B | $ 95.7 | 0.44 % | $ 4.47 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | Israel |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 237.14 | 2.07 % | $ 26.3 B | USA |
 |
DexCom
DXCM
|
28.2 B | $ 87.9 | 0.02 % | $ 34.3 B | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 164.85 | 0.78 % | $ 12.9 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Psychemedics Corporation
PMD
|
1.77 M | - | -1.84 % | $ 15.3 M | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Syneos Health
SYNH
|
4.59 B | - | - | $ 4.46 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 326.89 | 0.29 % | $ 27.2 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
3.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
5.67 M | - | -16.95 % | $ 1.54 M | USA |
 |
T2 Biosystems
TTOO
|
54.9 M | - | -39.35 % | $ 313 K | USA |
 |
Anixa Biosciences
ANIX
|
990 K | $ 3.07 | 0.66 % | $ 99.6 K | USA |
 |
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | USA |
 |
Meridian Bioscience
VIVO
|
1.3 B | - | - | $ 1.49 B | USA |
 |
Quotient Limited
QTNT
|
273 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 345.26 | 0.11 % | $ 27.7 B | Schweiz |
 |
Myriad Genetics
MYGN
|
598 M | $ 3.18 | 1.57 % | $ 294 M | USA |
 |
ENDRA Life Sciences
NDRA
|
4.49 M | $ 6.05 | 6.51 % | $ 4.76 M | USA |
 |
National Research Corporation
NRC
|
432 M | $ 21.53 | 1.32 % | $ 482 M | USA |
 |
Renalytix AI plc
RNLX
|
33.9 M | - | 5.66 % | $ 22.7 M | Britain |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.45 | 2.11 % | $ 6.41 M | USA |
 |
OPKO Health
OPK
|
1.34 B | $ 1.64 | 1.86 % | $ 1.23 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.35 | 3.85 % | $ 405 M | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 267.77 | 2.95 % | $ 46 B | USA |
 |
Surmodics
SRDX
|
578 M | - | - | $ 608 M | USA |
 |
Personalis
PSNL
|
380 M | $ 17.2 | 2.2 % | $ 1.53 B | USA |
 |
Quidel Corporation
QDEL
|
460 M | $ 13.97 | 0.29 % | $ 588 M | USA |